Folgen
Shirin Tavakoli
Shirin Tavakoli
Bestätigte E-Mail-Adresse bei helsinki.fi
Titel
Zitiert von
Zitiert von
Jahr
Exploring the impact of morphology on the properties of biodegradable nanoparticles and their diffusion in complex biological medium
R Ridolfo, S Tavakoli, V Junnuthula, DS Williams, A Urtti, JCM van Hest
Biomacromolecules 22 (1), 126-133, 2020
1022020
Ocular barriers to retinal delivery of intravitreal liposomes: Impact of vitreoretinal interface
S Tavakoli, K Peynshaert, T Lajunen, J Devoldere, EM Del Amo, ...
Journal of controlled release 328, 952-961, 2020
552020
Diffusion and protein corona formation of lipid-based nanoparticles in the vitreous humor: profiling and pharmacokinetic considerations
S Tavakoli, OK Kari, T Turunen, T Lajunen, M Schmitt, J Lehtinen, ...
Molecular pharmaceutics 18 (2), 699-713, 2020
432020
Light-activated liposomes coated with hyaluronic acid as a potential drug delivery system
OK Kari, S Tavakoli, P Parkkila, S Baan, R Savolainen, T Ruoslahti, ...
Pharmaceutics 12 (8), 763, 2020
332020
Intravitreal polymeric nanocarriers with long ocular retention and targeted delivery to the retina and optic nerve head region
V Junnuthula, A Sadeghi Boroujeni, S Cao, S Tavakoli, R Ridolfo, ...
Pharmaceutics 13 (4), 445, 2021
272021
Effect of PEGylation on assembly morphology and cellular uptake of poly ethyleneimine-cholesterol conjugates for delivery of sorafenib tosylate in hepatocellular carcinoma
M Monajati, S Tavakoli, SS Abolmaali, G Yousefi, AM Tamaddon
BioImpacts: BI 8 (4), 241, 2018
232018
Liposomal sunitinib for ocular drug delivery: A potential treatment for choroidal neovascularization
S Tavakoli, J Puranen, S Bahrpeyma, VE Lautala, S Karumo, T Lajunen, ...
International Journal of Pharmaceutics 620, 121725, 2022
192022
Pharmacokinetics of pullulan–dexamethasone conjugates in retinal drug delivery
E Kicková, A Sadeghi, J Puranen, S Tavakoli, M Sen, VP Ranta, ...
Pharmaceutics 14 (1), 12, 2021
142021
Imaging, quantitation and kinetic modelling of intravitreal nanomaterials
A Sadeghi, M Ruponen, J Puranen, S Cao, R Ridolfo, S Tavakoli, ...
International Journal of Pharmaceutics 621, 121800, 2022
132022
Nucleic acid delivery to differentiated retinal pigment epithelial cells using cell-penetrating peptide as a carrier
B Subia, M Reinisalo, N Dey, S Tavakoli, A Subrizi, M Ganguli, ...
European Journal of Pharmaceutics and Biopharmaceutics 140, 91-99, 2019
132019
Microencapsulation of (deoxythymidine)20–DOTAP complexes in stealth liposomes optimized by Taguchi design
S Tavakoli, AM Tamaddon, N Golkar, SM Samani
Journal of Liposome Research 25 (1), 67-77, 2015
122015
Characterization, stability, and in vivo efficacy studies of recombinant human CNTF and its permeation into the neural retina in ex vivo organotypic retinal explant culture models
J Itkonen, A Annala, S Tavakoli, B Arango-Gonzalez, M Ueffing, ...
Pharmaceutics 12 (7), 611, 2020
82020
Design and synthesis of lipid-mimetic cationic iridium complexes and their liposomal formulation for in vitro and in vivo application in luminescent bioimaging
JR Shakirova, A Sadeghi, AA Koblova, PS Chelushkin, E Toropainen, ...
RSC advances 10 (24), 14431-14440, 2020
62020
Solid lipid microparticles of lamotrigine: an injectable controlled release system for local delivery in nerve injuries
S Mohammadi-Samani, F Jalali, S Tavakoli, F Ahmadi
Journal of Drug Delivery Science and Technology 24 (4), 367-372, 2014
42014
Intravitreal liposomes as ocular drug delivery systems: vitreal interactions, retinal permeation and drug release characteristics
S Tavakoli
Dissertationes Scholae Doctoralis Ad Sanitatem Investigandam Universitatis …, 2021
12021
Supplementary Materials: Characterization, Stability, and in Vivo Efficacy Studies of Recombinant Human CNTF and its Permeation into the Neural Retina in ex Vivo Organotypic …
J Itkonen, A Annala, S Tavakoli, B Arango-Gonzalez, M Ueffing, ...
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–16